Literature DB >> 22476927

Management of squamous cell cancer of the oesophagus in a patient with a polyglandular endocrinopathy (APECED) and achalasia.

Orla Mc Cormack1, Marie Timlin, Anne Mc Gowan, Marie-Louise Healy, Narayanasamy Ravi, John V Reynolds.   

Abstract

INTRODUCTION: We report a case of a 37-year-old man, with a background of a rare polyglandular autoimmune syndrome and achalasia, who developed an oesophageal tumour. Both autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED) or type I polyglandular syndrome and achalasia confer increased risk of development of oesophageal squamous cell carcinoma.
METHODS: Despite having had multiple endoscopic examinations and dilatations in the recent past, this patient presented with dysphagia, and on endoscopy, he was found to have a mid-oesophageal tumour. A multidisciplinary team approach was vital in his management as careful monitoring of underlying disorders including Addison's disease and hypoparathyroidism were challenging during neoadjuvant chemoradiotherapy and in the perioperative period.
RESULTS: He made an uneventful recovery after a three-stage oesophagectomy, and histologically, he had a complete pathological response.
CONCLUSION: To our knowledge, this is the first successful outcome of a patient with APECED and oesophageal carcinoma in the literature.

Entities:  

Mesh:

Year:  2012        PMID: 22476927     DOI: 10.1007/s11605-012-1879-5

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  11 in total

Review 1.  Autoimmune polyendocrine syndromes.

Authors:  George S Eisenbarth; Peter A Gottlieb
Journal:  N Engl J Med       Date:  2004-05-13       Impact factor: 91.245

2.  Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in the Irish population.

Authors:  Maria Dominguez; Ellen Crushell; Tanja Ilmarinen; Eleanor McGovern; Sinead Collins; Ben Chang; Padraig Fleming; Alan D Irvine; Donal Brosnahan; Ismo Ulmanen; Nuala Murphy; Colm Costigan
Journal:  J Pediatr Endocrinol Metab       Date:  2006-11       Impact factor: 1.634

3.  A common mutation in Sardinian autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients.

Authors:  M C Rosatelli; A Meloni; A Meloni; M Devoto; A Cao; H S Scott; P Peterson; M Heino; K J Krohn; K Nagamine; J Kudoh; N Shimizu; S E Antonarakis
Journal:  Hum Genet       Date:  1998-10       Impact factor: 4.132

4.  Oral and oesophageal squamous cell carcinoma--a complication or component of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED, APS-I).

Authors:  Riina Rautemaa; Jarkko Hietanen; Sirkku Niissalo; Sinikka Pirinen; Jaakko Perheentupa
Journal:  Oral Oncol       Date:  2006-09-25       Impact factor: 5.337

5.  Autoimmune polyendocrinopathy--candidosis--ectodermal dystrophy (APECED): autosomal recessive inheritance.

Authors:  P Ahonen
Journal:  Clin Genet       Date:  1985-06       Impact factor: 4.438

6.  Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients.

Authors:  P Ahonen; S Myllärniemi; I Sipilä; J Perheentupa
Journal:  N Engl J Med       Date:  1990-06-28       Impact factor: 91.245

7.  Long-term outcomes following neoadjuvant chemoradiotherapy for esophageal cancer.

Authors:  John Vincent Reynolds; Cian Muldoon; Donal Hollywood; Narayanasamy Ravi; Suzanne Rowley; Ken O'Byrne; John Kennedy; Thomas J Murphy
Journal:  Ann Surg       Date:  2007-05       Impact factor: 12.969

8.  Current clinical approach to achalasia.

Authors:  Alexander J Eckardt; Volker F Eckardt
Journal:  World J Gastroenterol       Date:  2009-08-28       Impact factor: 5.742

9.  Decreased susceptibility of Candida albicans to azole antifungals: a complication of long-term treatment in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patients.

Authors:  Riina Rautemaa; Malcolm Richardson; Michael Pfaller; Pirkko Koukila-Kähkölä; Jaakko Perheentupa; Harri Saxén
Journal:  J Antimicrob Chemother       Date:  2007-08-17       Impact factor: 5.790

10.  Management of achalasia.

Authors:  Luca Dughera; Michele Chiaverina; Luca Cacciotella; Fabio Cisarò
Journal:  Clin Exp Gastroenterol       Date:  2011-02-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.